zelpultide alfa (AT-100) / Airway Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zelpultide alfa (AT-100) / Airway Therap
NCT04659122: A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia

Terminated
1b
5
US
AT-100, (rhSP-D)
Airway Therapeutics, Inc.
COVID-19, Undefined
02/23
02/23
2021-005752-10: Clinical trial to assess the safety of the drug named AT-100 in preterm neonates at high risk for development of bronchopulmonary dysplasia Studio clinico per valutare la sicurezza del farmaco AT-100 in neonati prematuri ad alto rischio di sviluppare la displasia broncopolmonare

Not yet recruiting
1
36
Europe
AT-100, [na], Lyophilisate for solution for injection
Airway Therapeutics, Inc., Airway Therapeutics, Inc.
Bronchopulmonary Dysplasia (BPD) Displasia Broncopolmonare (BPD), Bronchopulmonary Dysplasia Displasia Broncopolmonare, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
NCT04662151 / 2021-005752-10: A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Completed
1
37
Europe, US
AT-100, (rhSP-D), Air-sham
Airway Therapeutics, Inc., Airway Therapeutics, Inc.
Bronchopulmonary Dysplasia
08/23
05/24

Download Options